NHS England consults on plans for a sustainable Cancer Drugs Fund
NHS England is proposing changes to the way its Cancer Drugs Fund (CDF) operates, in order that it delivers maximum benefit for patients, within the resources available. Clinicians and cancer specialists believe the changes, if adopted, would: improve patient access to the most clinically effective drugs available through the fund; encourage pricing that delivers value […]